4 Shops Contend in $25 Mil. Drug Pitch

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.

NEW YORK Four finalists are vying for the account of a new urinary incontinence drug from Eli Lilly & Co. and Boehringer Ingelheim, according to sources.

The estimated $25 million assignment is for ad duties outside the U.S.

Contending are WPP Group’s J. Walter Thompson in London, Omnicom Group’s BBDO in Dusseldorf, Germany, Interpublic Group’s Foote, Cone & Belding in New York and Havas’ Euro RSCG, London, sources said.

AW+

INDEPENDENCE DAY SALE

Subscribe today!

APPLY PROMO CODE "JULY20" AT CHECK OUT FOR 20% OFF

View Subscription Options

Already a member? Sign in